FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885241421> ?p ?o ?g. }

• W2885241421 endingPage "3175" @default.
• W2885241421 startingPage "3153" @default.
• W2885241421 abstract "Periodontitis is a prevalent chronic inflammatory disease associated with dysbiosis. Although complement inhibition has been successfully used to treat periodontitis in animal models, studies globally analyzing inflamed tissue proteins to glean insight into possible mechanisms of action are missing. Using quantitative shotgun proteomics, we aimed to investigate differences in composition of inflammatory gingival tissue exudate (“gingival crevicular fluid”; GCF), before and after local administration of an inhibitor of the central complement component, C3, in nonhuman primates. The C3 inhibitor, Cp40 (also known as AMY-101) was administered locally in the maxillary gingival tissue of cynomolgus monkeys with established periodontitis, either once a week (1×-treatment; n = 5 animals) or three times per week (3×-treatment; n = 10 animals), for 6 weeks followed by another 6 weeks of observation in the absence of treatment. 45 GCF samples were processed for FASP digestion and liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis. Data were processed using the ProgenesisQI software. The statistical significance of differences between the groups was determined by RM-ANOVA, and a protein expression change was considered as a true regulation at >2-fold and p < 0.05. The human orthologues were subjected to Gene Ontology analyses using PANTHER. Data are available via ProteomeXchange with identifier PXD009502. 573 proteins with >2 peptides were longitudinally quantified. Both 3× and 1× administration of Cp40 resulted in significant down-regulation of dozens of proteins during the 6-week course of treatment as compared to baseline. Following drug withdrawal at 6 weeks, more than 50% of the down-regulated proteins showed increased levels at week 12. The top scored pathway was “complement activation, alternative pathway”, and several proteins involved in this pathway were down-regulated at 6 weeks. We mapped the proteomic fingerprint changes in local tissue exudate of cynomolgus monkey periodontitis in response to C3 inhibition and identified the alternative pathway of complement activation and leukocyte degranulation as main targets, which are thus likely to play significant roles in periodontal disease pathogenesis. Label-free quantitative proteomics strategies utilizing GCF are powerful tools for the identification of treatment targets and providing insights into disease mechanisms." @default.
• W2885241421 created "2018-08-22" @default.
• W2885241421 creator A5002516811 @default.
• W2885241421 creator A5007464693 @default.
• W2885241421 creator A5022897466 @default.
• W2885241421 creator A5025270532 @default.
• W2885241421 creator A5025915071 @default.
• W2885241421 creator A5033411656 @default.
• W2885241421 creator A5037729123 @default.
• W2885241421 creator A5040899814 @default.
• W2885241421 creator A5064785053 @default.
• W2885241421 creator A5074301183 @default.
• W2885241421 creator A5079000449 @default.
• W2885241421 creator A5084031628 @default.
• W2885241421 creator A5090561267 @default.
• W2885241421 date "2018-08-16" @default.
• W2885241421 modified "2023-10-16" @default.
• W2885241421 title "Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis" @default.
• W2885241421 cites W1604121414 @default.
• W2885241421 cites W172530508 @default.
• W2885241421 cites W1884635290 @default.
• W2885241421 cites W1906541968 @default.
• W2885241421 cites W1965448326 @default.
• W2885241421 cites W1969787878 @default.
• W2885241421 cites W1971422062 @default.
• W2885241421 cites W1990287652 @default.
• W2885241421 cites W1992774189 @default.
• W2885241421 cites W1993364032 @default.
• W2885241421 cites W1994214832 @default.
• W2885241421 cites W1994893732 @default.
• W2885241421 cites W2007559967 @default.
• W2885241421 cites W2008294135 @default.
• W2885241421 cites W2012758286 @default.
• W2885241421 cites W2020008649 @default.
• W2885241421 cites W2020122002 @default.
• W2885241421 cites W2023010129 @default.
• W2885241421 cites W2027404073 @default.
• W2885241421 cites W2030311878 @default.
• W2885241421 cites W2031215908 @default.
• W2885241421 cites W2036540053 @default.
• W2885241421 cites W2069697252 @default.
• W2885241421 cites W2072471109 @default.
• W2885241421 cites W2102895407 @default.
• W2885241421 cites W2106255922 @default.
• W2885241421 cites W2107639233 @default.
• W2885241421 cites W2108571057 @default.
• W2885241421 cites W2116308765 @default.
• W2885241421 cites W2135945302 @default.
• W2885241421 cites W2136648677 @default.
• W2885241421 cites W2136990670 @default.
• W2885241421 cites W2141124318 @default.
• W2885241421 cites W2145564736 @default.
• W2885241421 cites W2145877847 @default.
• W2885241421 cites W2146766390 @default.
• W2885241421 cites W2163085584 @default.
• W2885241421 cites W2167362969 @default.
• W2885241421 cites W2169628503 @default.
• W2885241421 cites W2230061649 @default.
• W2885241421 cites W2282499633 @default.
• W2885241421 cites W2396739985 @default.
• W2885241421 cites W2397512299 @default.
• W2885241421 cites W2421704473 @default.
• W2885241421 cites W2523032292 @default.
• W2885241421 cites W2545368922 @default.
• W2885241421 cites W2567086022 @default.
• W2885241421 cites W2607711862 @default.
• W2885241421 cites W2621121417 @default.
• W2885241421 cites W2748662058 @default.
• W2885241421 cites W2754247840 @default.
• W2885241421 cites W2770722600 @default.
• W2885241421 cites W2773076305 @default.
• W2885241421 cites W2795780297 @default.
• W2885241421 cites W3027143372 @default.
• W2885241421 doi "https://doi.org/10.1021/acs.jproteome.8b00263" @default.
• W2885241421 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6128774" @default.
• W2885241421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30111112" @default.
• W2885241421 hasPublicationYear "2018" @default.
• W2885241421 type Work @default.
• W2885241421 sameAs 2885241421 @default.
• W2885241421 citedByCount "23" @default.
• W2885241421 countsByYear W28852414212019 @default.
• W2885241421 countsByYear W28852414212020 @default.
• W2885241421 countsByYear W28852414212021 @default.
• W2885241421 countsByYear W28852414212022 @default.
• W2885241421 countsByYear W28852414212023 @default.
• W2885241421 crossrefType "journal-article" @default.
• W2885241421 hasAuthorship W2885241421A5002516811 @default.
• W2885241421 hasAuthorship W2885241421A5007464693 @default.
• W2885241421 hasAuthorship W2885241421A5022897466 @default.
• W2885241421 hasAuthorship W2885241421A5025270532 @default.
• W2885241421 hasAuthorship W2885241421A5025915071 @default.
• W2885241421 hasAuthorship W2885241421A5033411656 @default.
• W2885241421 hasAuthorship W2885241421A5037729123 @default.
• W2885241421 hasAuthorship W2885241421A5040899814 @default.
• W2885241421 hasAuthorship W2885241421A5064785053 @default.
• W2885241421 hasAuthorship W2885241421A5074301183 @default.
• W2885241421 hasAuthorship W2885241421A5079000449 @default.
• W2885241421 hasAuthorship W2885241421A5084031628 @default.

• next